期刊文献+

13例正常大小卵巢癌综合征的临床分析 被引量:2

CLINICAL ANALYSIS OF 13 CASES OF NORMAL-SIZED OVARY CARCINOMA SYNDROME
下载PDF
导出
摘要 目的探讨正常大小卵巢癌综合征的临床特点、诊断方法及治疗措施。方法回顾性分析2003~2008年经我院治疗及病理证实的正常大小卵巢癌综合征13例,大部分均最大限度切除肿瘤病灶,多数辅以多疗程联合化疗。结果除3例失访外,1例于术后34个月死亡,余下9例随访至2009年2月仍存活,为术后3~36个月。结论临床上遇到有卵巢正常大小,伴有与卵巢癌临床表现相同的综合征,但原发灶不明者,应高度警惕有正常大小卵巢癌综合征的存在,首选手术(剖腹探查或腹腔镜)明确诊断和治疗,术后辅以有针对性的化疗,可能获得较长的生存期。 Objective To evaluate the clinical features,diagnostic and treating methods of clinical normal - sized ovary carcinoma syndrome(NOCS). Methods 13 cases of NOCS which was confirmed by pathology and underwent treatment in our hospital from 2003 to 2008 were retrospectively reviewed. Most patients received relatively thorough surgical resection combined with multiple courses of adjuvant chemotherapy. Results 3 cases lose contact after operation. 1 case was died at 34 months later after operation. 9 cases still survive up to February 2009. They are surviving for 3 to 36 months up to February 2009 after operation. Conclusion If we meet with patients whose ovaries are in normal sizes and have the same clinical syndrome of ovary carcinoma but the origin is unknown ,we must pay great attention to NOCS. Operation is the first choice of diagnosis and treatment. Postoperative chemotherapy is essential to obtain longer survival time.
出处 《现代医院》 2009年第6期17-19,共3页 Modern Hospitals
关键词 卵巢肿瘤 病理学 诊断 治疗 正常大小卵巢癌综合征 Ovarian neoplasm, Pathology, Diagnosis, Treatment, NOCS
  • 相关文献

参考文献3

  • 1HATA K,HATA T,MAKIHARA K,et al.Preoperative diagnostic imaging of normal-sized ovary carcinoma syndrome[J].Int J Gynaecol Obstet,1991,35(3):259-264.
  • 2FEUER G A,SHEVCHUK M,CALANOG A.Normal-sized ovary carcinoma syndrome[J].Obstet Gynecol,1989,73(5 Pt 1):786-792.
  • 3曾定元,沈铿.卵巢正常大小癌综合征的研究进展[J].中华医学杂志,2005,85(16):1149-1151. 被引量:5

二级参考文献26

  • 1石雪君,郭燕燕,李竞贤,汤秀英,张莹,尹玲.卵巢外腹膜浆液性乳头状癌的临床及病理学分析[J].中华妇产科杂志,1996,31(12):711-713. 被引量:22
  • 2Feuer G.A, Shevchuk M, Calanog A. Normal-sized ovary carcinoma syndrom. Obstet Gynecol,1989,73(5 Pt 1):786-792.
  • 3Takekawa Y, Kimura M, Sakakibara M, et al. Pathological,cytological and immunohistochemical study of normal-sized ovary carcinoma syndrom. Rinsho Byori, 2001,49:66-70.
  • 4Kuwashima Y, Uehara T, Kurosumi M, et al. Pathological aspects of normal-sized ovarian carcinoma. Eur J Gynaecol Oncol, 1996,17:17-23.
  • 5Kebapci M, Vardareli E, Adapinar B, et al. CT findings and serum CA125 levels in malignant peritoneal mesothelioma:report of 11 new cases and review of literature. Eur Radiol, 2003,13:2620-2626.
  • 6Barbieri PG, Marinaccio A, Festa R, et al. Survival analysis of malignant mesothelioma treated in Brescia,northern Italy,1982-2000. Epidemiol Prev, 2004,28:107-113.
  • 7Hotta T, Taniguchi K, Kobayashi Y, et al. Chemotherapy and serum hyaluronic acid levels in malignant peritoneal mesothelioma. Hepatogastroenterology, 2004,51:1073-1083.
  • 8Yamazaki T, Hatano H, Suzuki A, et al. Normal-sized ovary carcinoma syndrome: histopathological analysis of 14 cases. Nippon Sanka Fujinka Gakkai Zasshi. 1995,47:27-34.
  • 9Halperin R,Zehavi S,Hadas E,et al. Immunohistochemical comparision of primary peritoneal and primary ovarian serous papillary carcinoma. Int J Gynecol Pathlo, 2001,20:341-345.
  • 10Bloss JD,Liao SY, Buller RE, et al. Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary. Gynecol Oncol,1993,50:347-351.

共引文献4

同被引文献39

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部